The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …

Allergic rhinitis (AR) and asthma represent global health problems for all age groups.
Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact …

Asthma is a serious health problem throughout the world. During the past two decades,
many scientific advances have improved our understanding of asthma and ability to manage …

Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A
Task Force, supported by the European Respiratory Society and American Thoracic Society …

For most patients, asthma is not controlled as defined by guidelines; whether this is
achievable has not been prospectively studied. A 1-year, randomized, stratified, double …

Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

Background Asthma is a major cause of disability, health resource utilization and poor
quality of life world-wide. We set out to generate estimates of the global burden of asthma in …

Background Elevated numbers of blood eosinophils are a risk factor for asthma
exacerbations. Reslizumab is a humanised anti-interleukin 5 monoclonal antibody that …

The 7-item Asthma Control Questionnaire (ACQ) has been validated to measure the goals of
asthma management as defined by international guidelines (minimisation of day-and night …